UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 31, 2006
QuadraMed Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 001-32283 | 52-1992861 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
12110 Sunset Hills Road, Suite 600, Reston, VA 20190
(Address of principal executive office and zip code)
(703) 709-2300
(Registrant’s telephone number, including area code)
(Not Applicable)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 8.01 | OTHER EVENTS. | |
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS. | |
| SIGNATURES | ||
| EXHIBIT INDEX | ||
| EXHIBIT 99.1 | QUADRAMED CORPORATION PRESS RELEASE, DATED OCTOBER 31, 2006. | |
On October 31, 2006, QuadraMed Corporation (the “Company”) issued a press release announcing that the Department of Veterans Affairs has awarded the Company a Task Order with a stated value of approximately $20.5 million under its existing Blanket Purchase Agreement with the Company. This Task Order renews the term license for QuadraMed EPS (Encoder Product Suite) for the government’s fiscal year 2007 and upgrades it with the Company’s VIP Compliance Suite in all 147 Veterans Affairs medical centers nationwide.
A copy of the Press Release is furnished as Exhibit 99.1, which is incorporated herein by reference in response to this Item 8.01.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
| Exhibit 99.1 | QuadraMed Corporation Press Release, dated October 31, 2006. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 2, 2006
| QuadraMed Corporation |
| /s/ David L. Piazza |
| David L. Piazza, Executive Vice President and Chief Financial Officer |
| Exhibit No. | Description | |
| 99.1 | QuadraMed Corporation Press Release, dated October 31, 2006. |